Sino Biopharmaceutical Limited: all 470 studies

Page 4 of 5. Open to participants first (164), then studies with results posted, then the rest; newest registration first within each.

• Study of LM-302 in Patients With Advance Solid TumorsCompletedNCT05161390Phase 1/2
• Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant TumorsTerminatedNCT05154630Phase 1/2
• A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian CancerStatus unknownNCT05145218Phase 3
• A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial CarcinomaStatus unknownNCT05121363Phase 2
• A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue SarcomaStatus unknownNCT05121350Phase 3
• A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant TumorsStatus unknownNCT05110807Phase 1
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I NeurofibromatosisStatus unknownNCT05107037Phase 1
• A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced MalignancyStatus unknownNCT05068921Phase 1
• A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOxStatus unknownNCT05068206Phase 2
• A Clinical Trial of TQC3721 Suspension for InhalationStatus unknownNCT05051930Phase 1
• A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant TumorsStatus unknownNCT05046847Phase 1
• Human Bioequivalence Test of Liraglutide InjectionCompletedNCT05029076Phase 1
• A Clinical Study of TQB3824 in Subjects With Advanced CancerStatus unknownNCT05028218Phase 1
• A Clinical Study of TQB3823 in Patients With Advanced Malignant TumorActive, not recruitingNCT05021367Phase 1
• A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk MyelofibrosisCompletedNCT05020652Phase 2
• A Study of TQB3820 in Patients With Hematological MalignanciesStatus unknownNCT05020639Phase 1
• A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I NeurofibromatosisTerminatedNCT05011019Phase 1/2
• Study of LM-102 in Patients With Advance Solid TumorsTerminatedNCT05008445Phase 1/2
• A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant TumorsStatus unknownNCT04975204Phase 1
• A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)Status unknownNCT04964479Phase 3
• Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)Status unknownNCT04956328Phase 3
• A Study of TQ05105 in Patients With Chronic Graft Versus Host DiseaseActive, not recruitingNCT04944043Phase 1/2
• A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)TerminatedNCT04941404Phase 1/2
• A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)CompletedNCT04925141Phase 4
• A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung CancerTerminatedNCT04924192Phase 2
• Phase I Clinical Trial of TQC2731 InjectionStatus unknownNCT04923607Phase 1
• A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal CarcinomaCompletedNCT04895345Phase 2
• A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced TumoursTerminatedNCT04882176Phase 1/2
• Phase 1 Trial of the TQB2928 Injection in Patients With Advanced CancersStatus unknownNCT04854681Phase 1
• A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal CancerActive, not recruitingNCT04854668Phase 3
• A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 TabletsTerminatedNCT04853498Phase 1
• A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic TumorsStatus unknownNCT04836663Phase 2
• A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell LymphomaStatus unknownNCT04827004Phase 2
• A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary CancerStatus unknownNCT04809142Phase 3
• A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaTerminatedNCT04808570Phase 1/2
• A Pharmacokinetic Study of TQB3101 in Chinese Healthy SubjectsCompletedNCT04804904Phase 1
• A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast CancerCompletedNCT04796623Phase 2
• Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.Status unknownNCT04768699Phase 1
• Study of LM-061 in Subjects in Advanced TumorsTerminatedNCT04737122Phase 1
• Study of LM-102 in Subjects in Advanced TumorsTerminatedNCT04735796Phase 1
• Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 CapsulesStatus unknownNCT04675060Phase 1
• FS120 Phase 1/1b Study in Patients With Advanced MalignanciesActive, not recruitingNCT04648202Phase 1
• A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid TumorsStatus unknownNCT04623892Phase 1
• A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical CancerStatus unknownNCT04623333Phase 2
• A Study of TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）Status unknownNCT04615468Phase 2
• A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma （DLBCL）Status unknownNCT04610970Phase 2
• A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial CancerCompletedNCT04574284Phase 2
• A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride InjectionCompletedNCT04569838Phase 2
• A Phase I Study of TQB728 Tablets on Tolerance and PharmacokineticsStatus unknownNCT04523285Phase 1
• A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal CancerActive, not recruitingNCT04523272Phase 3
• A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 TabletsStatus unknownNCT04481607Phase 1
• A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung CancerStatus unknownNCT04439890Phase 3
• A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological MalignanciesStatus unknownNCT04412577Phase 1
• A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant TumorStatus unknownNCT04412564Phase 2
• A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 TabletsStatus unknownNCT04408079Phase 1
• A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)Status unknownNCT04405505Phase 3
• A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)Status unknownNCT04398953Phase 2
• A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung CancerStatus unknownNCT04398940Phase 2
• A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.Status unknownNCT04385563Phase 3
• A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction AdenocarcinomaStatus unknownNCT04385550Phase 3
• Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 DiabetesStatus unknownNCT04373967Phase 3
• A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast CancerStatus unknownNCT04355520Phase 1/2
• A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)Active, not recruitingNCT04344158Phase 3
• A Study of TQB3455 Tablets in Subjects With Advanced MalignanciesStatus unknownNCT04340427Phase 1
• A Study of TQ05105 Tablets in Subjects With Myeloproliferative NeoplasmsCompletedNCT04339400Phase 1
• A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal CancerStatus unknownNCT04337879Phase 1/2
• A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH）Status unknownNCT04326348Phase 1
• A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone MetastasisStatus unknownNCT04325776Phase 2
• A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)Status unknownNCT04325763Phase 3
• A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)Status unknownNCT04324879Phase 2
• A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung CancerStatus unknownNCT04306926Phase 2
• A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)Status unknownNCT04306887Phase 2
• A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid TumorStatus unknownNCT04291248Phase 2
• A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)Status unknownNCT04278820Phase 2
• A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 CapsuleStatus unknownNCT04275583Phase 1
• A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 TabletsStatus unknownNCT04275050Phase 1
• A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 TabletsStatus unknownNCT04273815Phase 1/2
• A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological CancerStatus unknownNCT04236362Phase 1/2
• A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)Status unknownNCT04234607Phase 3
• A Study of Anlotinib in Subjects With Advanced MalignancyCompletedNCT04216082Phase 2
• A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine TumorsStatus unknownNCT04207463Phase 2
• A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest CancerStatus unknownNCT04203719Phase 2
• A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis BStatus unknownNCT04180150Phase 2
• A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 InjectionStatus unknownNCT04144855Phase 1
• A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant TumorsStatus unknownNCT04128085Phase 1
• Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter TrialStatus unknownNCT04106024Phase 2
• Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid TumorsCompletedNCT04096638Phase 1
• Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung CancerStatus unknownNCT04073550Phase 3
• Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung CancerStatus unknownNCT04073537Phase 3
• Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.Status unknownNCT04061109Phase 3
• Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.Status unknownNCT04060836Phase 1
• Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate CancerCompletedNCT04056754Phase 3
• Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With CrizotinibStatus unknownNCT04056572Phase 2
• Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT04009317Phase 3
• Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell LymphomaTerminatedNCT04002622Phase 2
• Study of TQB2450 Combined With Anlotinib in Subjects With Advanced CholangiocarcinomaStatus unknownNCT03996408Phase 1/2
• Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion InjuryStatus unknownNCT03995732Phase 2
• Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant MelanomaStatus unknownNCT03991975Phase 1/2
• Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes MellitusStatus unknownNCT03986073Phase 2
• Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung CancerStatus unknownNCT03983928Phase 1/2

← Sino Biopharmaceutical Limited overview and focus areas